Recent Updates
Recently added Catalysts
AMN

Amy C. Chang Vice President, Investor Relations 866.861.3229 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2015 RESULTS Quarterly revenue increases 36% to $328 million; reports EPS of $0.25 SAN DIEGO (

Key Takeaway: AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2015 RESULTS Quarterly revenue increases 36% to $328 million; reports EPS of $0.25 SAN DIEGO (May 6, 2015) AMN Healthcare Services, Inc. (NYSE: AHS), healthcare s innovator in workforce solutions and staffing services, today announced fi

Full Press Release Details

AMN HEALTHCARE ANNOUNCES FIRST
QUARTER 2015 RESULTS
Quarterly revenue increases 36% to $328 million; reports EPS of $0.25
SAN DIEGO (May 6, 2015) AMN Healthcare Services, Inc. (NYSE: AHS), healthcare s innovator in workforce solutions and staffing services,
today announced first quarter 2015 financial results exceeding the Company s guidance for revenue and adjusted EBITDA. First quarter financial highlights are as follows:
Dollars in millions, except per share amounts.
Q1 2015 % Change Q1 2014
Revenue $ 327.5 36 %
Gross profit $ 101.4 37 %
Net income $ 12.2 60 %
Diluted EPS $ 0.25 56 %
Adjusted Diluted EPS* $ 0.30 67 %
Adjusted EBITDA* $ 33.3 58 %
Amid positive trends in the healthcare industry, we continued to experience strong demand
and outstanding execution across all business segments, resulting in better than anticipated revenue and profitability growth during the first quarter, said Susan R. Salka, President and Chief Executive Officer of AMN Healthcare. The
pipeline of opportunities for our strategic workforce solutions offerings remains strong, and our recently added Avantas, Onward Healthcare, Locum Leaders and Medefis companies are performing and integrating very well into AMN s service
offerings. Our portfolio of differentiated workforce solutions and stronger recruitment and supply capabilities, combined with the favorable market conditions and the exceptional performance by our team, give us a continued optimistic outlook for
First Quarter 2015 Results
For the first quarter of 2015, consolidated revenue was $328 million, an increase of 36% from the same quarter last year and 17% sequentially.
First quarter revenue for the Nurse and Allied Healthcare Staffing segment was $229 million, up 40% (24% excluding acquisitions) from the same quarter last year and 20% sequentially. Locum Tenens Staffing segment revenue in the first quarter was $87
million, an increase of 30% (19% excluding acquisitions) from the same quarter last year and up 14% sequentially. First quarter Physician Permanent Placement Services segment revenue was $12 million, an increase of 11% from the same quarter last
year and lower by 1% sequentially.
First quarter gross margin of 31.0% was higher by 30 basis points than the same quarter last year and
higher by 70 basis points sequentially. The year-over-year and sequential gross margin improvements were driven both by organic and acquisition revenue growth of higher-margin workforce solutions businesses.
SG&A expenses for the first quarter were $72 million, representing 21.8% of revenue, compared to 22.7% in the same quarter last year and
22.1% in the prior quarter. The year-over-year and sequential improvements in SG&A expenses as a percentage of revenue were due primarily to operating leverage associated with the revenue growth. SG&A expenses in the quarter included
$1 million of acquisition and integration-related expenses.
First quarter net income was $12 million and net income per diluted share was $0.25. Excluding
the impact of amortization of intangible assets of $3 million and acquisition and integration-related expenses of $1 million, adjusted net income per diluted share was $0.30. First quarter adjusted EBITDA was $33 million, a year-over-year increase
of 58% and sequential increase of 32%. First quarter adjusted EBITDA margin of 10.2% represented a 140 basis point increase over prior year and 120 basis point increase from the prior quarter.
At March 31, 2015, cash and cash equivalents totaled $12 million. First quarter cash flow from operations was $9 million and capital
expenditures were $6 million. The Company ended the first quarter with total debt outstanding of $238 million, with a leverage ratio of 2.2 to 1.
Business Trends and Outlook
Company expects consolidated second quarter 2015 revenue of $335 to $340 million. Gross margin is expected to be 30.5% to 31.0%. SG&A expenses as a percentage of revenue are expected to be 22.0% to 22.5%, slightly higher than first quarter due
to increases in employee and other expenses to deliver consistent quality service to our clients. Integration-related expenses are expected to be approximately $1 million. Adjusted EBITDA margin is expected to be approximately 9.5%.
About AMN Healthcare
Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare s workforce solutions - including managed services programs, vendor management systems,
recruitment process outsourcing and consulting services - enable providers to successfully reduce complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. The Company provides unparalleled
access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. Clients include acute-care hospitals, community health centers and clinics, physician
practice groups, retail and urgent care centers, home health facilities, and many other healthcare settings. AMN Healthcare disseminates news and information about the Company through its website, which can be found at www.amnhealthcare.com.
Conference Call on May 7, 2015
AMN Healthcare Services, Inc. s first quarter 2015 conference call will be held on Thursday, May 7, 2015, at 5:00 p.m. Eastern Time.
A live webcast of the call can be accessed through AMN Healthcare s website at http://amnhealthcare.investorroom.com/presentations. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio
software. Interested parties may participate live via telephone by dialing (800) 230-1059 in the U.S. or (612) 234-9959 internationally. Following the conclusion of the call, a replay of the webcast will be available at the Company s
website. A telephonic replay of the call will be available at 7:30 p.m. Eastern Time on May 7, 2015, and can be accessed until 11:59 p.m. Eastern Time on May 21, 2015, by calling (800) 475-6701 in the U.S. or
(320) 365-3844 internationally, with access code 357522.
This earnings release contains certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the
Company s condensed consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin, and (3) adjusted diluted EPS. The Company
provides such non-GAAP financial measures because management believes that they are useful both to management and investors as a supplement, and not as a substitute, when evaluating the Company s operating performance. Additionally, management
believes that adjusted EBITDA, adjusted EBITDA margin and adjusted diluted EPS serve as industry-wide financial measures, and it uses adjusted EBITDA for making financial decisions and allocating resources. The non-GAAP measures in this release are
not in accordance with, or an alternative to, GAAP, and may be different from non-GAAP measures, or may be calculated differently than other similarly title-captioned non-GAAP measures, reported by other companies. They should not be used in
isolation to evaluate the Company s performance. A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the
table entitled Supplemental Financial and Operating Data under the caption entitled Reconciliation of Non-GAAP Items or on the Company s website at http://amnhealthcare.investorroom.com/financialreports. Additionally, from
time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company s website.
Forward-Looking Statements
contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include expectations regarding
the 2015 outlook and second quarter revenue, gross margin, SG&A expenses, integration-related expenses and adjusted EBITDA margin. The Company based these forward-looking statements on its current expectations, estimates and projections
about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these
forward-looking statements. Forward-looking statements are identified by words such as believe, anticipate, expect, intend, plan, will, may, estimates,
variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Factors that could cause actual
results to differ from those implied by the forward-looking statements contained in this press release are set forth in the Company s Annual Report on Form 10-K for the year ended December 31, 2014 and its other periodic reports as well as
the Company s current and other reports filed from time to time with the Securities and Exchange Commission. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated with the passage
Vice President, Investor Relations
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Comprehensive Income
(in thousands, except per share amounts)
Three Months Ended
March 31, December 31,
2015 2014 2014
Revenue $ 327,510 $ 240,881 $ 279,649
Cost of revenue 226,078 166,925 194,953
Gross profit 101,432 73,956 84,696
31.0 % 30.7 % 30.3 %
Operating expenses:
Selling, general and administrative 71,552 54,667 61,668
21.8 % 22.7 % 22.1 %
Depreciation and amortization 5,095 3,820 4,077
Total operating expenses 76,647 58,487 65,745
Income from operations 24,785 15,469 18,951
Interest expense, net, and other 1,807 1,846 1,329
Income before income taxes 22,978 13,623 17,622
Income tax expense 10,769 5,993 7,727
Net income $ 12,209 $ 7.630 $ 9,895
Net income per common share:
Basic $ 0.26 $ 0.16 $ 0.21
Diluted $ 0.25 $ 0.16 $ 0.20
Weighted average common shares outstanding:
Basic 47,146 46,354 46,634
Diluted 48,364 47,917 48,462
Other comprehensive income (loss) 68 (9 ) 113
Comprehensive income $ 12,277 $ 7,621 $ 10,008
AMN Healthcare Services, Inc.
Supplemental Financial and Operating Data
(dollars in thousands, except per share and operating data)
Three Months Ended
March 31, December 31,
2015 2014 2014
Revenue
Nurse and allied healthcare staffing $ 229,046 $ 163,450 $ 191,570
Locum tenens staffing 86,692 66,871 76,170
Physician permanent placement services 11,772 10,560 11,909
$ 327,510 $ 240,881 $ 279,649
Reconciliation of Non-GAAP Items:
Segment operating income (1)
Nurse and allied healthcare staffing $ 31,901 $ 19,972 $ 23,963
Locum tenens staffing 9,110 6,873 8,155
Physician permanent placement services 3,271 2,131 2,744
44,282 28,976 34,862
Unallocated corporate overhead 10,960 7,868 9,601
Adjusted EBITDA (2) 33,322 21,108 25,261
Adjusted EBITDA margin (3) 10.2 % 8.8 % 9.0 %
Depreciation and amortization 5,095 3,820 4,077
Share-based compensation 2,377 1,819 1,796
Acquisition and integration costs 1,065 0 437
Interest expense, net and other 1,807 1,846 1,329
Income before income taxes 22,978 13,623 17,622
Income tax expense 10,769 5,993 7,727
Net income $ 12,209 $ 7,630 $ 9,895
GAAP based diluted net income per share (EPS) $ 0.25 $ 0.16 $ 0.20
Adjustments (net of tax):
Amortization of intangible assets $ 0.04 $ 0.02 $ 0.02
Acquisition and integration costs $ 0.01 $ 0.00 $ 0.01
Adjusted diluted EPS (4) $ 0.30 $ 0.18 $ 0.23
Three Months Ended
March 31, December 31,
2015 2014 2014
Gross Margin
Nurse and allied healthcare staffing 29.8 % 29.0 % 28.6 %
Locum tenens staffing 29.4 % 29.9 % 28.8 %
Physician permanent placement services 65.7 % 63.0 % 66.1 %
Operating Data:
Nurse and allied healthcare staffing
Average clinicians on assignment (5) 7,223 5,633 6,030
Locum tenens staffing
Days filled (6) 54,260 44,749 48,391
As of March 31 As of December 31,
2015 2014 2014
Leverage ratio (7) 2.2 2.0 1.9
AMN Healthcare Services, Inc.
Condensed Consolidated Balance Sheets
(dollars in thousands)
March 31, 2015 December 31, 2014
Assets
Current assets:
Cash and cash equivalents $ 11,633 $ 13,073
Accounts receivable, net 221,001 186,274
Accounts receivable, subcontractor 34,191 28,443
Deferred income taxes, net 26,466 27,330
Prepaid and other current assets 29,065 27,550
Total current assets 322,356 282,670
Restricted cash, cash equivalents and investments 19,772 19,567
Fixed assets, net 36,674 32,880
Other assets 44,117 39,895
Goodwill 197,254 154,387
Intangible assets, net 179,877 152,517
Total assets $ 800,050 $ 681,916
Liabilities and stockholders equity
Current liabilities:
Accounts payable and accrued expenses 92,081 78,993
Accrued compensation and benefits 72,237 67,995
Current portion of revolving credit facility 30,000 18,000
Current portion of notes payable 7,500 7,500
Deferred revenue 3,137 3,177
Other current liabilities 2,662 2,630
Total current liabilities 207,617 178,295
Revolving credit facility 65,500 0
Notes payable 135,000 136,875
Deferred income taxes, net 37,198 32,491
Other long-term liabilities 83,972 77,674
Total liabilities 529,287 425,335
Commitments and contingencies
Stockholders equity 270,763 256,581
Total liabilities and stockholders equity $ 800,050 $ 681,916
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
Three Months Ended
March 31, December 31,
2015 2014 (8) 2014
Net cash provided by operating activities $ 8,687 $ 864 $ 5,039
Net cash used in investing activities (85,350 ) (4,709 ) (17,908 )
Net cash provided by (used in) financing activities 75,155 (2,457 ) 16,166
Effect of exchange rates on cash 68 (9 ) 113
Net decrease in cash and cash equivalents (1,440 ) (6,311 ) 3,410
Cash and cash equivalents at beginning of period 13,073 15,580 9,663
Cash and cash equivalents at end of period $ 11,633 $ 9,269 $ 13,073
Last updated: May 6, 2015